Yuan Chang-ji - Concepedia

Author

Yuan Chang-ji

Jilin University

Also Known As

CHANG-JI YUAN, CHANGJI YUAN, Chang-Ji Yuan, Chang-ji Yuan, ChangJi Yuan, Changji Yuan, Chang‐Ji Yuan, Yuan Chang-ji

Publications

565

Citations

H-Index

Concepts

All Affiliations

Jilin University First Hospital of Jilin University First Bethune Hospital of Jilin University Harvard University Jilin Medical University

About

Yuan Chang-ji is an author at Jilin University specializing in tumor biology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	130
2	Cell Biology	3	3	130
3	Health Sciences	1	1	71
4	Immunology	1	1	71
5	Pharmacology	1	1	32

Yuan Chang-ji

Publications

471

Citations

H-Index

Page 1

	Year	Citations
Shockwaves Induce Osteogenic Differentiation of Human Mesenchymal Stem Cells Through ATP Release and Activation of P2X7 Receptors Dahui Sun, Wolfgang G. Junger, Yuan Chang-ji, Stem Cells	2013	149
Cisplatin Restores TRAIL Apoptotic Pathway in Glioblastoma-Derived Stem Cells through Up-regulation of DR5 and Down-regulation of c-FLIP Lijuan Ding, Yuan Chang-ji, Wei Feng, Cancer Investigation ApoptosisImmunologyCell DeathHigh-grade GliomasCancer Biology	2011	71
Shockwaves increase T-cell proliferation and IL-2 expression through ATP release, P2X7 receptors, and FAK activation Tiecheng Yu, Wolfgang G. Junger, Yuan Chang-ji, American Journal of Physiology-Cell Physiology	2009	56
Differential expression of filamin A and its clinical significance in breast cancer Huimin Tian, XIU-HUA LIU, Wei Han, Oncology Letters	2013	54
Inhibition of Filamin-A Reduces Cancer Metastatic Potential Xi Jiang, Jingyin Yue, Huimei Lu, International Journal of Biological Sciences	2013	52
The Effect of Green Tea Extract and EGCG on the Signaling Network in Squamous Cell Carcinoma Xiaoliang Liu, David Zhang, Wiley Zhang, Nutrition and Cancer Chemoprevention StrategySquamous Cell CarcinomaSignaling NetworkCell DeathTumor Biology	2011	32
In vivo and in vitro inhibition of human liver cancer progress by downregulation of the μ-opioid receptor and relevant mechanisms Lu Jin, Zefeng Liu, Lingling Zhao, Oncology Reports	2013	30
K-Ras mutation-mediated IGF-1-induced feedback ERK activation contributes to the rapalog resistance in pancreatic ductal adenocarcinomas Wei Feng, Yan Liu, Anita C. Bellail, Cancer Letters Tumor BiologySignaling PathwayPancreatic CancerReceptor Tyrosine KinasePancreatic Ductal Adenocarcinomas	2012	27

Page 1